2 min read
Takeda Faces Partial Privilege Waiver in Actos Antitrust Case
In In re Actos Antitrust Litigation, the U.S. District Court for the Southern District of New York addressed the scope of privilege in an antitrust case concerning the diabetes drug ACTOS. Plaintiffs alleged that Takeda Pharmaceuticals delayed...
Read More